Marino, Stram & Associates LLC Gilead Sciences, Inc. Transaction History

Marino, Stram & Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$61.87 - $69.38 $1,423 - $1,595	-23 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $500 - $560	-8 Reduced 25.81%	23 $1,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $2,011 - $2,346	-31 Reduced 50.0%	31 $2,000
Q4 2017 Mar 09, 2018	BUY	$71.15 - $83.52 $4,411 - $5,178	62	62 $4,000

1,878

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Marino, Stram & Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Marino, Stram & Associates LLC with notifications on news.